24Serious

CRISPR

Ask VT AI

View News Summary

British journalist Sami Hamdi detained at San Francisco airport, raising tensions over free speech, national security, and political pressure on enforcement decisions.
FIA investigates near-miss between Lawan Lawson and marshals at Mexico City Grand Prix, raising concerns about safety protocols.
Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.

20 hours

First 100 Days

See how you scored in predicting Trump's first 100 days

Latest News

CRISPR, Biotechnology

CRISPR Therapeutics Unveils SyNTase Gene Editing Data Showing Breakthrough 95% Success at ESGCT 2025

100% left coverage1 source

CRISPR, Biotechnology

CRISPR Therapeutics Unveils SyNTase Gene Editing Data Showing Breakthrough 95% Success at ESGCT 2025

100% left coverage1 source

CRISPR Therapeutics Unveils SyNTase Gene Editing Data Showing Breakthrough 95% Success at ESGCT 2025

CRISPR Therapeutics Unveils SyNTase Gene Editing Data Showing Breakthrough 95% Success at ESGCT 2025

CRISPR, Biotechnology

CRISPR Therapeutics, Sirius Initiate Phase 2 European Trial of FXI Inhibitor SRSD107 for VTE Prevention

100% left coverage1 source

CRISPR, Biotechnology

CRISPR Therapeutics, Sirius Initiate Phase 2 European Trial of FXI Inhibitor SRSD107 for VTE Prevention

100% left coverage1 source

CRISPR Therapeutics, Sirius Initiate Phase 2 European Trial of FXI Inhibitor SRSD107 for VTE Prevention

CRISPR Therapeutics, Sirius Initiate Phase 2 European Trial of FXI Inhibitor SRSD107 for VTE Prevention

CRISPR, Academia

Tulane Researchers Develop CRISPR Tongue Swab Revolutionizing Tuberculosis Detection

100% left coverage1 source

CRISPR, Academia

Tulane Researchers Develop CRISPR Tongue Swab Revolutionizing Tuberculosis Detection

100% left coverage1 source

Tulane Researchers Develop CRISPR Tongue Swab Revolutionizing Tuberculosis Detection

Tulane Researchers Develop CRISPR Tongue Swab Revolutionizing Tuberculosis Detection

CRISPR, Biotechnology

CRISPR Therapeutics Reports $208.5M Q2 Loss, Activates 75 Global Treatment Centers

100% left coverage1 source

CRISPR, Biotechnology

CRISPR Therapeutics Reports $208.5M Q2 Loss, Activates 75 Global Treatment Centers

100% left coverage1 source

CRISPR Therapeutics Reports $208.5M Q2 Loss, Activates 75 Global Treatment Centers

CRISPR Therapeutics Reports $208.5M Q2 Loss, Activates 75 Global Treatment Centers

CRISPR, Biotechnology

Japanese Court Upholds UC CRISPR Patent in Global Legal Battle

100% left coverage1 source

CRISPR, Biotechnology

Japanese Court Upholds UC CRISPR Patent in Global Legal Battle

100% left coverage1 source

Japanese Court Upholds UC CRISPR Patent in Global Legal Battle

Japanese Court Upholds UC CRISPR Patent in Global Legal Battle

CRISPR, Biotechnology

CRISPR Center Launches with $20M to Develop Personalized Therapies

100% left coverage2 sources

CRISPR, Biotechnology

CRISPR Center Launches with $20M to Develop Personalized Therapies

100% left coverage2 sources

CRISPR Center Launches with $20M to Develop Personalized Therapies

CRISPR Center Launches with $20M to Develop Personalized Therapies

CRISPR, Biotechnology

CRISPR Therapeutics Named to TIME 100 Most Influential Companies List

100% left coverage1 source

CRISPR, Biotechnology

CRISPR Therapeutics Named to TIME 100 Most Influential Companies List

100% left coverage1 source

CRISPR Therapeutics Named to TIME 100 Most Influential Companies List

CRISPR Therapeutics Named to TIME 100 Most Influential Companies List

Ask VT AI

View News Summary

British journalist Sami Hamdi detained at San Francisco airport, raising tensions over free speech, national security, and political pressure on enforcement decisions.
FIA investigates near-miss between Lawan Lawson and marshals at Mexico City Grand Prix, raising concerns about safety protocols.
Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.

20 hours

First 100 Days

See how you scored in predicting Trump's first 100 days

Most Reported By
News from CRISPR